Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: Role of the EP2 receptor

Journal of Bone and Mineral Research

Volumn 20, Issue 1, 2005, Pages 23-29

  Ono, Katsuhiro ^a   Kaneko, Hironori ^a   Choudhary, Shilpa ^a   Pilbeam, Carol C ^a   Lorenzo, Joseph A ^a   Akatsu, Takuhiko ^b   Kugai, Nobuo ^b   Raisz, Lawrence G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Macrophage colony stimulating factor; Osteoclastogenesis; Prostaglandin receptors; RANKL; T cells

Indexed keywords

COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; CARRIER PROTEIN; MEMBRANE PROTEIN; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL MATURATION; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; LYMPHOCYTE DEPLETION; MOUSE MUTANT; PHYSIOLOGY; SPLEEN;

ANIMALS; BONE RESORPTION; CARRIER PROTEINS; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; DINOPROSTONE; FEMALE; LYMPHOCYTE DEPLETION; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, PROSTAGLANDIN E; SPLEEN; T-LYMPHOCYTES;

EID: 21644445936     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2005.20.1.23     Document Type: Article

References (28)

1. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG 1995 The role of prostaglandins in the regulation of bone metabolism. Clin Orthop 313:36-46.
2. Pilbeam CC, Harrison JR, Raisz LG 2002 Prostaglandins and bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principle of Bone Biology. Academic Press, London, UK, pp. 979-994.
3. Akatsu T, Takahashi N, Debari K, Morita I, Murota S, Nagata N, Takatani O, Suda T 1989 Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell cultures. J Bone Miner Res 4:29-35.
4. Akatsu T, Takahashi N, Udagawa N, Imamura K, Yamaguchi A, Sato K, Nagata N, Suda T 1991 Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 6:183-189.
5. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki N, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
6. 2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 30:567-573.
7. 2 cooperated with TRANCE in osteoclast induction from hemopoietic precursors: Synergistic activation of differentiation, cell spreading, and fusion. Endocrinology 140:1927-1935.
8. Okada Y, Lorenzo JA, Freeman AM, Tomita M, Morham SG, Raisz LG, Pilbeam CC 2000 Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 105:823-832.
9. Li X, Okada Y, Pilbeam CC, Lorenzo JA, Kennedy CRJ, Breyer RM, Raisz LG 2000 Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 141:2054-2061.
10. 2. J Endocrinol 158:R1-R5.
11. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T 2000 The role of prostaglandin E receptor subtypes (EP1, EP2, EP3 and EP4) in bone resorption: An analysis using specific agonists for the respective EPs. Endocrinology 141:1554-1559.
12. Kennedy CR, Zhang Y, Brandon S, Guan Y, Coffee K, Funk CD, Magnuson MA, Oates JA, Breyer MD, Breyer RM 1999 Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med 5:217-220.
13. Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, Anderson PA, Malouf NN, Koller BH 1997 The prostaglandin receptor EP4 triggers remodeling cardiovascular sys-tem at birth. Nature 390:78-81.
14. Boyde A, Ali NN, Jones SJ 1984 Resorption of dentine by isolated osteoclasts in vitro. Br Dent J 156:216-220.
15. Hurley MM, Lee SK, Raisz LG, Bernecker P, Lorenzo J 1998 Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22:309-316.
16. John V, Hock JM, Short LL, Glasebrook AL, Galvin RJ 1996 A role for CD8+T lymphocytes in osteoclast differentiation in vitro. Endocrinology 137:2457-2463.
17. Horwood NJ, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, Dunn AR, Martin TJ, Gillespie MT 1998 Interleukin 18 inhibits osteoclast formation via T cell production of Granulocyte Macrophage Colony-Stimulating Factor. J Clin Invest 101:595-603.
18. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309.
19. Grcevic D, Lee SK, Marusic A, Lorenzo JA 2000 Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. J Immunol 165:4231-4238.
20. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R 2000 Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106:1229-1237.
21. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T 2000 T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and INF-gamma. Nature 408:600-605.
22. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R 2001 T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and independent mechanisms. J Bone Miner Res 16:328-337.
23. Horwood NJ, Elliott J, Martin TJ, Gillespie MT 2001 IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166:4915-4921.
24. Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN 2003 IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci USA 100:125-130.
25. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T 2000 Tumor necrosis factor-α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-285.
26. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno K, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT 2001 Transforming growth factor B affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 16:1784-1794.
27. Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato H, Mano H, Kumegawa M, Hakeda Y 2000 Endogenous production of TGF-β is essential for osteoclastogenesis induced by a combination of receptor activator of NF-κB ligand and macrophage-colony-stimulating factor. J Immunol 165:4254-4263.
28. Kaneko H, Ono K, Lee S-K, Lorenzo JA, Toyama Y, Pilbeam CC, Raisz LG 2004 Prostaglandin E2 stimulation of osteoclast formation in hematopoietic cell cultures is mediated by a soluble T cell factor. J Bone Miner Res 18:S236.